Entity > Corporation > US > New York City New York > Exelixis
About Exelixis
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Exelixis
| Company Attribute | Value |
| Name | Exelixis |
| Url | exelixis |
| Wikidata | wikidata |
Exelixis
New York City, US
18 Sep 2023
Exelixis
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.exelixis.com/
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the ...
Rich Sitelinks
People Also Ask
https://www.linkedin.com › company › exelixis
Mar 16, 2012 — Exelixis | 45035 followers on LinkedIn. Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give ...
https://en.wikipedia.org › wiki › Exelixis
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. ...
https://twitter.com/ExelixisInc?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Twitter Boxes
https://finance.yahoo.com › quote › EXEL
Find the latest Exelixis, Inc. (EXEL) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://finance.yahoo.com/quote/EXEL/profile/
See the company profile for Exelixis, Inc. (EXEL) including business summary, industry/sector information, number of employees, business summary, ...
https://www.globaldata.com › All Companies
Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment ...
https://www.cnbc.com › quotes › EXEL
Get Exelixis Inc (EXEL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Related Searches
exelixis meaning
exelixis drugs
Exelixis stock price
Knowledge Panel
Exelixis (Biotechnology company)
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
-
Stock price : EXEL (NASDAQ) $21.81 -0.46 (-2.07%)Sep 15, 4:00 PM EDT - Disclaimer
-
Headquarters : Alameda, CA
-
CEO : Michael M. Morrissey (Jul 2010–)
-
Subsidiaries : Exelixis U.S., LLC, Exelixis Plant Sciences, Inc, MORE
-
Founded : November 15, 1994, Cambridge, MA
-
Revenue : 1.435 billion USD (2021)
-
President : Michael M. Morrissey